Navigation Links
Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
Date:5/1/2008

SAN DIEGO, May 1 /PRNewswire/ -- Astute Medical, Inc. today announced it has raised $6.25 million in an initial financing round led by De Novo Ventures. The proceeds will primarily be used to fund research and development aimed at the identification and validation of protein biomarkers with the goal of finding high potential diagnostic candidates.

"This investment is an exciting event that lays the foundation for our research and development activities," said Christopher Hibberd, Astute Medical chief executive officer. "We believe the participation of our lead investor De Novo Ventures demonstrates confidence in our ability to develop innovative diagnostic tests for use in acute hospital settings."

"Astute Medical has enormous potential to identify and deliver novel diagnostic tests that address costly diseases and medical conditions," said Fred Dotzler, managing director at De Novo Ventures. "We're delighted to work with Astute Medical and see promise in their goal of bringing innovative solutions to hospitals where poor diagnostic technologies contribute to delays and higher costs."

Astute Medical, founded in 2007, is led by Christopher Hibberd and Paul McPherson Ph.D., former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at

Biosite for 10 years, most recently as senior vice president corporate development. Dr. McPherson was at Biosite for fourteen years, most recently as vice president research and development.

About Astute Medical, Inc.

Astute Medical is dedicated to improving diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Astute Medical will develop te
'/>"/>

SOURCE Astute Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Astute Nanotechnology celebrates first year of success
2. Excruciatingly Embarrassing Moment for The Medical Board of California: Complete Meltdown of the Friday, April 25th Quarterly Meeting: by T. L. Kittle
3. OPEN LETTER: Medical Journal Calls Upon Barack Obama to Set the Record Straight on AIDS Virus
4. Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference
5. Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center
6. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
7. BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology
8. ATS Medical Announces First Frontiers in Cryoablation Symposium
9. Medical journal calls upon Barack Obama to do much more
10. ACP hosts largest medical education meeting for general and subspecialty internists
11. Flashpoint Medica Named Agency of Year by Medical Advertising News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2008)...elevised skin health program, the first of its kin... issues affecting an increasingly diverse,America,...ay, May 24, 2008., SAN FRANCISCO, May 20 /PRNewsw...ial designed to educate and inform the public abou...the Women,s Dermatologic Society (WDS),is pleased ...
(Date:5/20/2008)...ELMSFORD, Mass., May 20 /PRNewswire-FirstCall/ -- ... leading provider of specialized,high-performance...d signal,processing applications, announced that m...s business on Thursday, May 29, 2008 at the Cowen ...nce. The Conference will be,held at the New York P...
(Date:5/20/2008)...archers at the Peninsula Medical School in the Sou... San Raffaele Scientific Institute in Milan and Ca...ed a protein that is key to the regeneration of da...uld with further research lead to understanding di...de clues to methods of repairing damage in the cen...
(Date:5/20/2008)...ur years of paperless prescription use yields prac... health plans and policy makers, WASHINGTON, MAY ...th,Initiative (eHI) and the Center for Improving M...ate of a widely anticipated report detailing the,i... on physicians,consumers, employers, health plans...
Breaking Medicine News(10 mins):Health News:Women's Dermatologic Society Announces Collaboration on 'America's Ethnic Skin: An Al Roker Health Special' 2Health News:Women's Dermatologic Society Announces Collaboration on 'America's Ethnic Skin: An Al Roker Health Special' 3Health News:Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008 2Health News:Protein key to neuro-regeneration 2Health News:eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results 2Health News:eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results 3
...ccording to a study by the investigators at John H...m can be improved by reporting as well as recordin... Hopkins researchers said ‘Human error rates are ...g and reporting on the errors voluntarily plus ste...
...ll India Institute of Medical Sciences (AIIMS) dea...e feels of being subjected to humiliation by some ...eka, a leading ENT surgeon in the country and an e...ow contemplating leaving the premier institution o...
...t has been reported that towards the end of last y...st ever-triple organ transplant//. Surgeons at Sy...t the surgery on a 33-year-old woman, Leanne Myles... Wales. Leanne Myles was reported to be on her dea...
...he German scientists have stated that four people .../. The scientists, who had only just announced ab...rlier this year. They also went on to state that t...d cases of avian flu that were being passed on fro...
Other Medicine News:Health News:Voluntary Error-Reporting System Ensures Patient Safety 2Health News:Voluntary Error-Reporting System Ensures Patient Safety 3Health News:Voluntary Error-Reporting System Ensures Patient Safety 4Health News:Another Senior Doctor From AIIMS Contemplates Leaving Due to Infighting 2Health News:Another Senior Doctor From AIIMS Contemplates Leaving Due to Infighting 3Health News:Four Deaths Due To Bird Flu Caught From Wild Birds 2
(Date:5/20/2008)...Data Presented at the 2008 International Conferenc...cic Society, TORONTO, May 20 /PRNewswire-FirstCal...lmirall, S.A. today presented results from four cl... aclidinium bromide, an,investigational treatment ...Data from four preclinical studies further describ...
(Date:5/20/2008)...ysis Reveals Overall Survival Could be Extended if...reatment Identified by ChemoFx, CHICAGO, May 20 /...ed,today that the ChemoFx(R) Assay, a cell-based t...nt,s tumor to various chemotherapies,correlates w...patients with,primary ovarian cancer. Patients who...
(Date:5/20/2008)...CRANBURY, N.J., May 20 /- P...today that dosing has been initiated in a Phase,2a...atriuretic peptide,receptor A agonist, in subjects...ebo-controlled and double-blinded, and will includ...s many as 35 subjects will be,included, with six a...
(Date:5/20/2008)...NEW YORK, May 20 /- Delcath...hard Taney, President and Chief Executive,Officer,...ompany,s pivotal,Phase III clinical trial today at...leaders attending the Rodman & Renshaw 5th Annual ...ts updated patient recruitment levels for the Phas...
Breaking Medicine Technology:Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 2Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 3Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited 2Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited 3Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 1Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 2Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 3Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 4Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 5Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 6Schering Plough Highlights PEGINTRON 28TM 29 Clinical Data Presentations at the American Association for the Study of Liver Diseases 28AASLD 29 2007 700 71 in 7 Americans over age 70 has dementia 4977 11 in 7 Americans over age 70 has dementia 4977 21 in 7 Americans over age 70 has dementia 4977 31 in 7 Americans over age 70 has dementia 4977 4New brain cells listen before they talk 1026 1Rosemary chicken protects your brain from free radicals 1023 1Rosemary chicken protects your brain from free radicals 1023 2
MAGNETOM Allegra is the ultimate brain machine. This 3T MR scanner has been optimized for best image quality and fastest imaging of the brain, all in a highly compact design. ,These features pro
Signa Profile is built on the Signa foundation to deliver speed & image quality.
...I Platelet Concentrate System is a point-of-care s...et Concentrate (also referred to as Platelet Rich ...a small sample of blood. The Symphony II PCS conce...re found in the platelets. The platelet concentrat...
With the Leica D2D V3 video and photography system you can produce fantastic digital videos and pictures with the highest resolution.
Medicine Products: